Upcoming prostate cancer CureTalk on February 9

The next, scheduled prostate cancer CureTalk will be at 6:00 p.m. Eastern time on February 9, 2016, and will address the use of newer imaging and genomic testing methods in the diagnosis and management of prostate cancer.

Over the past 3 years or so there has been a great deal of new opportunity associated with our understanding of how best to use such techniques as multiparametric MRI scans and PET/CT scans in attempts to accurately image prostate cancer lesions before and after first-line treatment. Similarly, there has been expanding use of genomic tests (Prolaris, Oncotype Dx, Confirm MD, Decipher, and others) to assess prostate cancer risk based on tissue samples before and after treatment. The goal is often to clearly appreciate the risk factors affecting individual patients and optimize decisions about the applicability of simple monitoring (active surveillance) as opposed to invasive treatment in the newly diagnosed or to identify how best to manage higher-risk patients after first-line treatment — either before or after signs of biochemical recurrence.

Our primary speaker for this program will be Dr. David I. Lee of the University of Pennsylvania. Dr. Lee will address how he and his colleagues at the University of Pennsylvania are currently applying these techniques within their large, prostate cancer practice group. Please click here to register for this program.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: